KDR and ovarian cancer: VEGFR has been found to be overexpressed in many cancer types such as melanoma, medulloblastoma and ovarian cancer.39 A reduction in VEGFR-2 results in a reduction in blood flow to tumor cells, thereby suppressing tumor angiogenesis.40